Federal health officials push effort to spur cheaper biotech drugs
PositiveHealth

Federal health officials are taking significant steps to encourage the development of more affordable biotech drugs, which are crucial for many Americans battling autoimmune diseases and cancers. This initiative aims to lower healthcare costs and improve access to essential treatments, making a real difference in the lives of patients who rely on these medications.
— Curated by the World Pulse Now AI Editorial System





